Commonly, IBD is treated with immunosuppressive therapies including corticosteroids, immunomodulators, biologic agents including monoclonal antibody inhibitors of tumor necrosis factor (TNF) alpha, interleukin 12/23, integrins, and small molecules such as Janus kinase (JAK) inhibitors [7]. Here, TNF is linked to inflammatory bowel disease.